Role of TRPM8 in dorsal root ganglion in nerve injury-induced chronic pain by Lin Su et al.
RESEARCH ARTICLE Open Access
Role of TRPM8 in dorsal root ganglion in nerve
injury-induced chronic pain
Lin Su, Chao Wang, Yong-hao Yu, Yong-ying Ren, Ke-liang Xie and Guo-lin Wang*
Abstract
Background: Chronic neuropathic pain is an intractable pain with few effective treatments. Moderate cold
stimulation can relieve pain, and this may be a novel train of thought for exploring new methods of analgesia.
Transient receptor potential melastatin 8 (TRPM8) ion channel has been proposed to be an important molecular
sensor for cold. Here we investigate the role of TRPM8 in the mechanism of chronic neuropathic pain using a rat
model of chronic constriction injury (CCI) to the sciatic nerve.
Results: Mechanical allodynia, cold and thermal hyperalgesia of CCI rats began on the 4th day following surgery
and maintained at the peak during the period from the 10th to 14th day after operation. The level of TRPM8
protein in L5 dorsal root ganglion (DRG) ipsilateral to nerve injury was significantly increased on the 4th day after
CCI, and reached the peak on the 10th day, and remained elevated on the 14th day following CCI. This time
course of the alteration of TRPM8 expression was consistent with that of CCI-induced hyperalgesic response of the
operated hind paw. Besides, activation of cold receptor TRPM8 of CCI rats by intrathecal application of menthol
resulted in the inhibition of mechanical allodynia and thermal hyperalgesia and the enhancement of cold
hyperalgesia. In contrast, downregulation of TRPM8 protein in ipsilateral L5 DRG of CCI rats by intrathecal TRPM8
antisense oligonucleotide attenuated cold hyperalgesia, but it had no effect on CCI-induced mechanical allodynia
and thermal hyperalgesia.
Conclusions: TRPM8 may play different roles in mechanical allodynia, cold and thermal hyperalgesia that develop
after nerve injury, and it is a very promising research direction for the development of new therapies for chronic
neuroapthic pain.
Background
Chronic neuropathic pain is a refractory pain character-
ized by its complex mechanisms and diverse clinical
manifestations [1]. Traditional therapies usually bring
about many side effects [2]. Moderate cold stimuli can
relieve pain [3], which provides an inspiration for devel-
oping new treatments of chronic pain. Recently, transi-
ent receptor potential (TRP) channel family has been
proposed to play an important role in thermosensation
in mammals. Six thermosensitive ion channels of this
family have been discovered, including TRPV1, TRPV2,
TRPV3, TRPV4, TRPM8 and TRPA1. Among them,
TRPM8 and TRPA1 are responsive to cold stimuli [4].
TRPM8 is a ligand-gated non-selective cation channel
involved in detection of sensations such as coolness. It
is permeable to monovalent cations sodium, potassium,
and cesium and divalent cation calcium. TRPM8 is acti-
vated by cooling and exogenous chemicals such as
menthol and icilin, with an activation temperature of
approximate 25-28°C [5-9]. In contrast, TRPA1 is acti-
vated at about 17°C [10,11]. This channel is not required
for the transduction of cold sensation in physiological
conditions [12,13], but it is involved in mediating cold
hypersensitivity after inflammatory injury [14]. All these
findings greatly promote the progress in exploring the
relationship between temperature and pain. Studies have
shown that levels of TRPM8 protein [15] and RNA [16]
were both increased in rats with chronic neuropathic
pain. In addition, inflammatory factors such as H+, bra-
dykinin and phospholipase [17-19], and altering intracel-
lular pH [17] can both affect the activation of TRPM8.
These suggested that TRPM8 ion channel may be* Correspondence: wang_guolin@hotmail.com
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closely related to hyperalgesia induced by neurological
diseases and inflammation.
In previous studies, much attention has been focused
on the role of TRPM8 in the formation of cold hyperal-
gesia caused by nerve injury. For example, TRPM8 was
proposed to induce increased sensitivity to cold in mice
with chronic neuropathic pain [20]. However, some
investigators suspected this point of view and put for-
ward that compared with TRPM8, TRPA1 was more
likely to play a substantial role in the mechanism of
chronic nerve injury-induced cold hyperalgesia [21]. In
contrast, another study suggested that neither TRPM8
nor TRPA1 was likely to contribute directly to cold
hyperalgesia in rats with nerve injury [22]. So far, there
are few studies exploring whether or not TRPM8 plays
a similar role in mechanical allodynia, cold and thermal
hyperalgesia, which are most commonly seen clinically
that develop after nerve injury. In this study, we simul-
taneously test the alteration of cold, mechanical and
thermal sensitivity in chronic constriction injury (CCI)
model of neuropathic pain in rats, which facilitates the
comparative study of the role of TRPM8 in the mechan-
ism of these three different types of sensitized pain
responses.
In the present study, we firstly demonstrate the varia-
tion trend of TRPM8 protein expression in L5 dorsal
root ganglia (DRG) ipsilateral to nerve injury with the
development and maintenance of pain hypersensitivity
of the operated hindpaw of CCI rats. Thereafter how
activation or inhibition of TRPM8 channel influences
the behavioral sensitization of CCI rats and the expres-
sion of TRPM8 protein in DRG is investigated.
Results
Alteration of TRPM8 protein expression following CCI
This part of the experiment is used to investigate
whether the alteration in TRPM8 level is related to the
mechanism of chronic neuropathic pain. We firstly
explore the behavioral performance of hyperalgesia after
CCI. Cold and thermal hyperalgesia and mechanical
allodynia were measured before operation (baseline) and
on the 1st, 4th, 7th, 10th and 14th day after operation.
Cold hyperalgesia was measured using the cold plate
test. Compared with the total number of brisk lifts of
operated hind paw in sham-operated rats, the value for
brisk lifts of CCI rats was significantly increased on day
4 postligature placement (7.33 ± 2.01 vs 6.16 ± 2.02, P <
0.05) (Figure 1A). This difference reflected a heightened
sensitivity to cold stimuli. The increased number of
brisk lifts persisted through day 7 (34.17 ± 3.68 vs 6.00
± 2.10, P < 0.01), and reached the peak on day 10 (46.83
± 5.98 vs 6.66 ± 1.99, P < 0.01), and remained increased
on day 14 following ligation (45.33 ± 5.36 vs 5.66 ±
2.36, P < 0.01). Thermal hyperalgesia was assessed by
hot plate test. Time course of CCI-induced thermal
hyperalgesia (Figure 1B) was the same as that of CCI-
induced cold hyperalgesia. Value for heat-evoked paw
withdrawal latency (PWL) of CCI rats began to decrease
on day 4 (7.55 ± 0.90 s vs 7.94 ± 0.69 s, P < 0.05), and
reached a minimum on day 10 (3.48 ± 0.40 s vs 7.84 ±
0.45 s, P < 0.01) post-surgery. Mechanical allodynia was
assessed by Von Frey filament assay. Time course of
mechanical sensitivity (Figure 1C) following sciatic nerve
ligation was also consistent with that of CCI-induced
cold sensitivity, except that paw withdrawal threshold
(PWT) reached a minimum on day 14 (4.46 ± 1.12 g vs
27.28 ± 1.36 g, P < 0.01) following ligature placement. It
can be seen that cold and thermal hyperalgesia and
mechanical allodynia began on day 4 following CCI and
maintained at the peak from day 10 to day 14 after liga-
ture placement.
Injury-induced alteration in TRPM8 level in sensory
neurons could underlie the development of behavioral
sensitivity. Therefore, we examined the alteration of
gross expression of TRPM8 protein in ipsilateral L5
DRG before operation (baseline) and on the 1st, 4th,
7th, 10th and 14th day after operation using immuno-
histochemistry and western blotting. Level of TRPM8
protein was expressed as the percentage of TRPM8
positive neurons relative to total counted DRG neu-
rons in immunohistochemistry or the ratio of density
of TRPM8 band to that of b-actin band in western
blotting. DRG sections displayed positive staining for
TRPM8 mainly in the small-sized neurons, and the
distribution of TRPM8 positive neurons was not chan-
ged after CCI. Percentages of TRPM8 positive neurons
of CCI rats were significantly increased relative to
values at corresponding time points of sham-operated
rats on day 4 (7.1 ± 0.7%; 52 of 732 neurons; n = 24
fields vs 5.8 ± 0.4%; 42 of 719 neurons; n = 24 fields, P
< 0.05), day 7 (8.8 ± 0.6%; 71 of 803 neurons; n = 24
fields vs 6.2 ± 0.7%; 49 of 788 neurons; n = 24 fields, P
< 0.01), day 10 (14.0 ± 0.8%; 110 of 781 neurons; n =
24 fields vs 5.7 ± 0.5%; 46 of 801 neurons; n = 24
fields, P < 0.01) and day 14 (13.7 ± 0.7%; 109 of 796
neurons; n = 24 fields vs 6.2 ± 0.6%; 48 of 771 neu-
rons; n = 24 fields, P < 0.01) postligature placement
(Figure 2A). In immunoblotting, TRPM8 antibody
labeled a dense band at approximately 123 kDa, which
was consistent with the molecular weight of TRPM8
protein. And b-actin protein, as a control, ran at about
42 kDa. Analytic result of immunoblotting was similar
to that of immunohistochemistry. TRPM8 level of CCI
rats was first significantly increased on day 4 after sur-
gery (80.52 ± 10.65% vs 65.59 ± 8.10%, P < 0.05) com-
pared to that of sham-operated rats, and reached the
peak on day 10 (126.78 ± 13.56% vs 64.87 ± 8.01%, P <
0.01) and remained significantly elevated on day 14
Su et al. BMC Neuroscience 2011, 12:120
http://www.biomedcentral.com/1471-2202/12/120
Page 2 of 15
Figure 1 Assessment of behavioral reflex sensitization in CCI model of neuropathic pain. A, Cold sensitivity assessed by cold plate test. B,
Thermal sensitivity assessed by hot plate test. C, Mechanical sensitivity assessed by Von Frey filament assay. Data are expressed as mean ± SEM.
*P < 0.05, **P < 0.01 vs. sham-operated rats (t test).
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Figure 2 TRPM8 expression in ipsilateral L5 DRGs of CCI and sham-operated rats. A, TRPM8 protein staining in L5 DRG sections. Arrows
indicate TRPM8 positive neurons. The graph shows the percentage of TRPM8 positive neurons. B, TRPM8- immunoblotting of L5 DRGs. b-actin
expression is shown as a control. The graph shows the ratio of density of TRPM8 band to that of b-actin band. Data are expressed as mean ± SEM.
*P < 0.05, **P < 0.01 vs. sham-operated rats (t test). Magnification of immunohistochemical images is 400 ×, and scale bars represent 25 μm.
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after operation (123.98 ± 11.73% vs 66.75 ± 9.32%, P <
0.01) (Figure 2B).
This part of study revealed that TRPM8 protein
expression in L5 DRG ipsilateral to nerve injury was
increased from the 4th to 14th day after CCI. This upre-
gulation corresponded well with the development and
maintenance of nerve injury-induced hyperalgesia of
operated hind paw. These findings imply that the upre-
gulation of TRPM8 protein may be involved in the
mechanism of chronic neuropathic pain.
Effect of menthol on hyperalgesic response and the
expression of TRPM8 protein of CCI rats
We have found that the increased expression of TRPM8
protein was related to the hyperalgesia induced by CCI.
In order to further elucidate the role of TRPM8 channel
in the mechanism of chronic neuropathic pain, we
infused menthol, the activator of TRPM8, into the sub-
arachnoid space of CCI rats to investigate the effect of
TRPM8 activation on development of hyperalgesia fol-
lowing nerve injury. Menthol or its control, normal sal-
ine, was infused into CCI or sham-operated rats
through intrathecal catheter on the 14th day after the
establishment of pain model, when CCI rats were at
peak levels of behavioral sensitization.
We observed that application of menthol to CCI rats
significantly attenuated mechanical allodynia and ther-
mal hyperalgesia. PWT was increased from 4.54 ± 1.53
g to 20.86 ± 1.90 g (Figure 3A), and PWL from 3.35 ±
0.40 s to 6.79 ± 0.65 s (Figure 3B). But menthol also
resulted in an increase of the number of brisk lifts from
46.15 ± 4.98 to 70.37 ± 8.00 (Figure 3C), which implied
the enhanced cold sensitivity of CCI rats. Infusion of
normal saline to CCI or sham-operated rats, and appli-
cation of menthol to sham-operated rats all did not pro-
duce behavioral changes (Figure 3).
Menthol could greatly change the behavioral sensitiza-
tion of CCI rats, and next, we tried to ascertain whether
the influence of menthol on neuropathic reflex sensitiza-
tion was relevant to the alteration in TRPM8 level. We
found that expression levels of TRPM8 protein in CCI
rats receiving menthol and CCI rats receiving normal
saline were obviously higher than those in sham-oper-
ated rats receiving menthol and sham-operated rats
receiving normal saline (Figure 4). However, there were
no statistical significances in the percentage of TRPM8
positive neurons (Figure 4A) and the ratio of density of
TRPM8 band to that of b-actin band (Figure 4B)
between menthol-treated CCI rats (14.4 ± 1.3%; 104 of
722; n = 24 fields and 120.65 ± 12.97%, respectively)
and normal saline-treated CCI rats (13.9 ± 1.5%; 107 of
769; n = 24 fields and 128.31 ± 14.09%, respectively).
This suggested that although intrathecal administration
of menthol to CCI rats significantly influenced the
hyperalgesic response, it did not affect the total expres-
sion of TRPM8 protein in ipsilateral L5 DRG of CCI
rats. Percentage of TRPM8 positive neurons did not dif-
fer in sham-operated rats infused with menthol or with
normal saline (Figure 4), implying that menthol also did
not influence the expression of TRPM8 protein in
sham-operated rats.
Effect of TRPM8 gene knockdown on hyperalgesic
response of CCI rats
Our study suggested that TRPM8 expression was upre-
gulated after peripheral nerve injury. And we have also
investigated the effect of TRPM8 activation on CCI rats.
Next, whether selective knockdown of TRPM8 expres-
sion affected behavioral reflex sensitization of CCI rats
was examined. Here, TRPM8 antisense oligonucleotide
(ASODN) was injected intrathecally to knockdown
TRPM8 protein, and mismatch oligonucleotide
(MMODN) was used as the control of ASODN.
We found that number of brisk lifts of ASODN-trea-
ted CCI rats was obviously lower (8.07 ± 1.80 vs 50.99 ±
6.35, P < 0.01) than that of MMODN-treated CCI rats
(Figure 5A), indicating the application of ASODN alle-
viated cold hyperalgesia of rats with chronic neuropathic
pain. But neither PWT (Figure 5B) nor PWL (Figure
5C) was different between these two groups. There were
no statistical differences in value for brisk lifts (Figure
5A), PWT (Figure 5B) and PWL (Figure 5C) between
sham-operated rats receiving ASODN and those receiv-
ing MMODN.
We showed that the percentage of TRPM8 positive
neurons (Figure 6A) and the ratio of density of TRPM8
band to that of b-actin band (Figure 6B) in MMODN-
treated CCI rats were 13.3 ± 1.4% (104 of 782 neurons;
n = 24 fields) and 148.82 ± 17.38%, respectively. In con-
trast, values of ASODN-treated CCI rats were signifi-
cantly lower (1.0 ± 0.2%; 7 of 720 neurons; n = 24 fields
and 10.72 ± 3.51%, respectively). Level of TRPM8 pro-
tein in sham-operated rats receiving ASODN was also
obviously lower than that in sham-operated rats receiv-
ing MMODN (Figure 6). Interestingly, there was no sta-
tistical significance in the level of TRPM8 protein
between ASODN-treated CCI rats (1.0 ± 0.2%; 7 of 720
neurons; n = 24 fields and 10.72 ± 3.51%, respectively)
and ASODN-treated sham-operated rats (1.2 ± 0.3%; 9
of 763 neurons; n = 24 fields and 9.56 ± 2.35%, respec-
tively) (Figure 6). In order to examine the specificity of
TRPM8 antisense reagent used in our study, we com-
pared the level of TRPV1 protein using immunoblotting
in L5 DRG from naïve rats with that from rats intrathe-
cally treated with TRPM8 ASODN during the prior 5
consecutive days. We found that TRPV1 immunoreac-
tivity, at approximately 90 kDa, did not differ between
these two kinds of rats, which was informative to
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Figure 3 Effect of menthol on behavioral reflex sensitization of CCI rats. A, Mechanical sensitivity assessed by Von Frey filament assay. B,
Thermal sensitivity assessed by hot plate test. C, Cold sensitivity assessed by cold plate test. Data are expressed as mean ± SEM. **P < 0.01 vs.
pre-drug (paired t test).
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Figure 4 Effect of menthol on expression of TRPM8 protein in ipsilateral L5 DRGs of CCI rats. Immunohistochemical staining (A) and
western blot analysis (B) of TRPM8 protein in L5 DRGs from sham-operated rats treated with normal saline or menthol and CCI rats treated with
normal saline or menthol. Data are expressed as mean ± SEM. **P < 0.01 vs. Sham-NS rats; §§P < 0.01 vs. Sham-Menthol rats (one-way ANOVA
followed by SNK test). Magnification of immunohistochemical images is 400 ×, and scale bars represent 25 μm. Arrows indicate TRPM8 positive
neurons.
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Figure 5 Effect of TRPM8 ASODN on behavioral reflex sensitization of CCI rats. A, Cold sensitivity assessed by cold plate test. B, Mechanical
sensitivity assessed by Von Frey filament assay. C, Thermal sensitivity assessed by hot plate test. Data are expressed as mean ± SEM. **P < 0.01
vs. CCI-MMODN rats (one-way ANOVA followed by SNK test).
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Figure 6 Effect of TRPM8 ASODN on expression of TRPM8 protein in ipsilateral L5 DRGs of CCI rats. Immunohistochemical staining (A)
and western blot analysis (B) of TRPM8 protein in L5 DRGs from sham-operated rats treated with MMODN or ASODN and CCI rats treated with
MMODN or ASODN. TRPV1 immunoreactivity (B) is used to examine the specificity of TRPM8 antisense experiment. Data are expressed as mean
± SEM. **P < 0.01 vs. CCI-MMODN rats; §§P < 0.01 vs. Sham-MMODN rats (one-way ANOVA followed by SNK test). Magnification of
immunohistochemical images is 400 ×, and scale bars represent 25 μm. Arrows indicate TRPM8 positive neurons.
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confirm the specificity of TRPM8 ASODN in targeting
TRPM8 (Figure 6B).
We can see that downregulation of TRPM8 protein
induced by ASODN can attenuate cold hyperalgesia of
CCI rats, but it had no effect on nerve injury-induced
mechanical and thermal hypersensitivity.
Discussion
The present study investigated the role of cold receptor
TRPM8 in primary afferent neurons in the pathogenesis
of chronic neuropathic pain. Firstly, we studied the
development of sensitized pain behaviors and alteration
of TRPM8 expression after CCI to illuminate whether
TRPM8 might participate in the mechanism of nerve
injury-induced reflex sensitization. Then we observed
the effect of TRPM8 activation or down regulation of
TRPM8 expression on the nociceptive thresholds of CCI
rats by intrathecal administration of menthol or TRPM8
ASODN.
Upregulation on TRPM8 protein in ipsilateral L5 DRG
correlates with pain hypersensitivity following CCI
Immunofluorescence revealed that TRPM8-immunor-
eactive neurons were significantly increased in ipsilateral
L5 DRG of CCI rats [15]. Another study using ribonu-
clease protection assay showed that CCI induced an
increase of TRPM8 RNA in DRG ipsilateral to nerve
injury [16]. However, the level of TRPM8 mRNA was
decreased in spared nerve injury animals [23]. In our
study, we observed the upregulation of TRPM8 protein
after CCI. Here, the increase in level of TRPM8 protein
was first evident on the 4th day after CCI, and the level
reached the peak on the 10th day, and remained signifi-
cantly elevated on the 14th day postligature placement,
concurrent with time course of hyperalgesic response of
CCI rats that the decrease of nociceptive thresholds
began on day 4 following CCI and persisted up to day
14 post-surgery. It can be seen that the upregulaion of
TRPM8 expression in DRG is associated with the
mechanism of behavioral sensitization induced by nerve
injury.
Activation of TRPM8 attenuates mechanical and thermal
hypersensitivity, but also enhances cold hypersensitivity
Menthol at dose of 100 μg/kg was applied intrathecally
in our study, the dose of which was determined accord-
ing to the result of our preliminary experiment. In one
previous study, menthol of 125 μg/kg~260 μg/kg was
used to activate TRPM8 receptor [24]. Therefore,
menthol of 260 μg/kg was used as the initial dose in our
preliminary experiment. We gradually reduced the
amount of menthol and found that the hyperalgesic
response of CCI rats was also obviously affected even if
the dose of menthol was reduced to 90 μg/kg. Because
the purpose of our study was to perform qualitative eva-
luation of the effect of TRPM8 activation on CCI rats,
rather than explore the optimal dose of menthol in acti-
vating TRPM8, we decided to use menthol of 100 μg/kg
in our study in order to facilitate the calculation of the
dose of menthol.
Our study demonstrated that intrathecal application of
menthol to CCI rats significantly reduced mechanical
allodynia and thermal hyperalgesia, which reflected that
activation of TRPM8 receptor in the spinal cord inhib-
ited nerve injury-induced behavioral sensitization to
mechanical and thermal stimuli. Previous study reported
that activation of peripheral TRPM8 receptor induced
by topical application of icilin, another TRPM8 agonist,
to the paws ipsilateral to nerve injury also produced
robust reversal of CCI-induced thermal hyperalgesia and
mechanical allodynia [24]. The mechanism by which the
activation of TRPM8-mediated signal transduction path-
way inhibited neuropathic sensitization may involve
Group II and Group III metabotropic Glutamate Recep-
tors (Group II/III mGluRs). Under physiological condi-
tions, synaptic knobs on axons of nociceptive neurons
connect with dorsal horn neurons to form synapses,
through which the nociceptive information is trans-
mitted. Activation of cool sensory neurons expressing
TRPM8 produces synaptic release of glutamate. Then
glutamate acts through inhibitory Group II/III mGluRs
located either presynaptically on nociceptive neurons or
postsynaptically on dorsal-horn neurons, and finally
inhibits the input of nociceptive information [24].
In Colburn’s study, homozygous TRPM8-deficient
(TRPM8-/-) mice were generated using the method of
homologous recombination, whose physiological proper-
ties such as span and behavioral characteristics were not
different from those of wild type (TRPM8+/+) mice.
TRPM8 mRNA and protein levels could not be detected
in sensory neurons of TRPM8-/- mice. Prior to CCI,
application of acetone to hindpaw of TRPM8+/+ mice
caused paw lifting, but acetone could not result in beha-
vioral changes in TRPM8-/- mice. Following sciatic liga-
tion, TRPM8+/+ mice exhibited an enhanced sensitivity
to acetone. However, acetone sensitivity of TRPM8-/-
mice was not increased at any time after CCI [20].
Besides, Caspani et al [22] observed the activation of
TRPM8 by topical application of menthol to the ipsilat-
eral hind paw of CCI mice resulted in the enhancement
of hypersensitivity to cold. In our study, cold sensitivity
of CCI rats was significantly enhanced after intrathecal
administration of menthol. These two studies and ours
draw a similar conclusion that TRPM8 may play a cru-
cial role in mediating cold-induced pain after nerve
injury. However, Caspani et al [22] also reported that
the expression of TRPM8 mRNA in DRG of CCI mice
was significantly downregulated. Thus they pointed out
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that cold hypersensitivity in neuropathic pain states was
not dependent on increased expression of TRPM8 in
DRG. In contrast, in our experiments, after CCI and
sham-operated rats were both intrathecally treated with
menthol, cold sensitivity of CCI rats was obviously
higher than that of sham-operated rats, and the level of
TRPM8 protein in ipsilateral L5 DRG of CCI rats
receiving menthol was also significantly higher than that
of sham-operated rats receiving menthol, which implies
that enhanced cold hypersensitivity after chronic nerve
injury may rely on the increased expression of TRPM8
protein in DRG. We consider that the discrepancies in
usage method of menthol, topical in theirs and intrathe-
cal in ours, and the research level of molecule, mRNA
in theirs and protein in ours, may contribute to the dif-
ferent conclusions about the role of TRPM8 in the for-
mation of neuropathic cold hyperalgesia.
The mechanism of menthol-induced increased cold
hyperalgesia in rats with chronic neuropathic pain may
be that menthol can lower the voltage required for the
activation of TRPM8 channel, which is a voltage sensi-
tive channel activated by membrane depolarization,
thereby leading to the enhanced cold sensitivity [25].
Decreased expression of TRPM8 protein inhibits reflex
sensitization to cold after CCI
In the present study, we explored the role of TRPM8 in
CCI-induced cold hypersensitivity by reducing the
expression of TRPM8 protein. Other researchers also
investigated the effect of downregulation of TRPM8
expression on cold hyperalgesia of CCI rats. Proudfoot
et al [24] found that the development of CCI-induced
cold hyperalgesia was unaffected although TRPM8 pro-
tein expression was greatly reduced by TRPM8 ASODN.
This discovery is opposite to ours. The reason may be
the relatively smaller knockdown amplitude of TRPM8
protein in their study (reduced by 74.6%) compared
with that in our study (reduced by 92.8%) after intrathe-
cal ASODN. We intrathecally injected TRPM8 antisense
reagent into CCI rats twice a day for 5 consecutive days.
But in Proudfoot’s research, TRPM8 ASODN was insis-
tently delivered intrathecally over 13 days using mini-
pump containing oligonucleotides which was connected
to intrathecal catheter. Although the dose of TRPM8
ASODN used for each rat in Proudfoot’s study (168 μg
for each rat) is very similar to the dose used in our
research (180 μg for each rat), the difference in infusion
mode may influence the knockout effect of antisense
reagent on TRPM8 protein, and finally leads to two dif-
ferent conclusions.
A comparative study of role in the mechanism of
nerve injury-induced cold allodynia between TRPM8
and TRPA1 was also carried out [21]. It was demon-
strated that TRPA1 mRNA expression was increased in
the nearby uninjured L4 DRG from the 1st to 14th day
after L5 spinal nerve ligation (SNL), contemporaneous
with the development of L5 SNL-induced neuropathic
cold hyperalgesia of the ipsilateral hind paw. However,
the expressions of TRPM8 mRNA and protein in the L4
DRG were not changed within the 14 days’ trial period.
Moreover, L5 SNL-induced cold hyperalgesia was inhib-
ited by intrathecal TRPA1, but not TRPM8 ASODN.
Therefore, this study proposed that the increased
TRPA1 in uninjured L4 DRG neurons was likely to play
a substantial role in the mechanism of cold hyperalgesia
in neuropathic states. This point of view is inconsistent
with ours that knockdown of the TRPM8 gene by
ASODN targeting TRPM8 attenuated nerve injury-
induced cold hyperalgesia. Discrepancies in neuropathic
pain model and the level of TRPM8 expression may be
the reasons for this inconsistence. Intrathecal application
of TRPM8 ASODN to SNL rats only lowered the level
of TRPM8 protein by 25% [21]. The relatively small
decrease in TRPM8 expression is not sufficient to signif-
icantly reduce TRPM8-mediated exaggerated sensitivity
to cold.
A noteworthy question is it seems to be a paradox
that intrathecal injection of menthol into CCI rats not
only suppressed mechanical allodynia and thermal
hyperalgesia but also enhanced cold hyperalgesia. That
is to say, the inhibitory effect of TRPM8 activation on
mechanical allodynia and thermal hyperalgesia was
achieved at the expense of increased cold sensitivity. We
must emphasize that the purpose of this study is to
investigate the role of TRPM8 channel in the mechan-
ism of chronic neuropathic pain, and explore whether
TRPM8 may be a novel potential target gene for therapy
of chronic pain. The result of our animal experiment
has proved that some treatments targeting TRPM8 can
really relieve chronic pain, suggesting that it is worth-
while to further explore the pathogenesis of chronic
neuropathic pain in terms of cold receptor. The next
step is to seek ways to make full use of TRPM8-
mediated analgesia and minimize even abolish cold
hyperalgesia induced by the activation of TRPM8 chan-
nel, such as exploring the most appropriate degree of
TRPM8 activation or reducing TRPM8-mediated
enhanced cold sensitivity by intervening with other tar-
gets except TRPM8 channel.
Conclusions
To those who are suffering from chronic pain, cold sti-
muli of different degree can bring entirely different per-
ceptions. However, in the process of achieving TRPM8-
mediated analgesic effect, it is still not very clear that
TRPM8 receptor should be activated or inhibited, and
this is also the focus of the present study. Our results
show that upregulation of TRPM8 protein corresponds
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well with the induction and maintenance of sensitized
pain responses of ipsilateral hind paw caused by nerve
injury. Activation of TRPM8 channel reverses the reflex
sensitization to mechanical and thermal stimuli, whereas
it enhances cold hyperalgesia as well. On the other
hand, downregulation of TRPM8 protein results in the
inhibition of cold hypersensitivity, but it makes no
impact on nerve injury-induced mechanical allodynia
and thermal hyperalgesia. We can see that the function
of TRPM8 in the mechanism of hyperalgesic response
after nerve injury is extremely crucial and complex.
Activating TRPM8 alone will not produce satisfactory
analgesia, neither will inhibiting this channel alone. So,
in future studies, we will attempt to find ways to avoid
hypersensitivity to cold stimuli induced by TRPM8 acti-
vation while utilizing TRPM8-mediated analgesia, which
should lead to a deeper understanding of the role of
TRPM8 in pain, and ultimately produce more effective
treatments for chronic neuropathic pain.
Methods
Animals
Adult male Sprague-Dawley (SD) rats weighing 250-280
g (aged 7-8 weeks) were provided by Experimental Ani-
mal Center of Academy of Military Medical Sciences.
Rats were housed in groups of three to four under a
standard 12-hour light/dark cycle with access to food
and water ad libitum for at least 1 week before the
beginning of the experiments. Animal testing procedures
and general handling complied with the ethical guide-
lines and standards established by the institutional ani-
mal care and use committee of Tianjin medical
University and the local experiment ethics committee.
In the experiment exploring the alteration of TRPM8
protein expression following CCI, ninety-six rats were
randomly divided into group CCI and group sham
operation (n = 48 each). Eight rats in each group were
randomly selected to receive behavioral testing at the
following six time points: before operation, on the 1st,
4th, 7th, 10th and 14th day after operation. After beha-
vioral testing at each time point, all eight rats of each
group were killed, and ipsilateral L5 DRGs were dis-
sected out for determination of TRPM8.
In the experiment exploring the effect of menthol on
CCI rats, thirty-two rats were randomly divided into
four groups (n = 8 each): group sham-operated rats with
normal saline (Sham-NS), group sham-operated rats
with menthol (Sham-Menthol), group CCI rats with
normal saline (CCI-NS) and group CCI rats with
menthol (CCI-Menthol).
In the experiment exploring the effect of ASODN on
CCI rats, thirty-two rats were also randomly divided
into four groups (n = 8 each): group sham-operated rats
with TRPM8 mismatch oligonucleotide (MMODN) 60
μg/kg (Sham-MMODN), group sham-operated rats with
TRPM8 antisense oligonucleotide (ASODN) 60 μg/kg
(Sham-ASODN), group CCI rats with MMODN 60 μg/
kg (CCI-MMODN) and group CCI rats with ASODN
60 μg/kg (CCI-ASODN).
Intrathecal catheter placement
A polyethylene catheter was implanted in each rat
through foramen magnum according to the method
described by Yaksh et al [26]. Twenty-four hours later,
rats exhibiting neurological deficits were excluded from
the experiments while the rest received 2% lidocaine 20
μl through intrathecal catheter. If the rat exhibited
paralysis of hind limb, the catheter was sure to be in the
subarachnoid space.
Construction of CCI model
CCI or sham operation was performed 5 days after
intrathecal catheter placement. The surgical procedure
was based on that described by Bennett and Xie [27].
Rats were anesthetized using 10% chloral hydrate (350
mg/kg intraperitoneally), and the common sciatic nerve
of the right hind paw was exposed at the level of the
middle of the thigh by blunt dissection through the
biceps femoris. Proximal to the sciatic trifurcation,
approximate 7 mm of nerve was freed, and 4 tight liga-
tures of sterilized 2-0 silk thread were placed around
the sciatic nerve with about 1 mm spacing. The desired
degree of constriction was to slow down blood flow,
without arresting it. In sham-operated animals, the same
surgical procedure was followed until the sciatic nerve
was exposed, but no ligatures were applied. All surgical
procedures were performed by the same person under
aseptic conditions.
Intrathecal administration of drugs
1R, 2S, 5R-(-)-menthol (Bio Basic Inc., Canada) at dose
of 100 μg/kg was applied intrathecally in a 20 μl volume
of 0.9% normal saline-based vehicle on the 14th day
after CCI or sham operation. In case of group sham-
operated rats with normal saline and CCI rats with
normal saline, equal volume 0.9% normal saline was
administered in the same manner. TRPM8 antisense
oligonucleotides (ASODN; 5’C*T*CGAAGGACATC
TTGCCGTG*G*3’) and mismatch oligonucleotides
(MMODN; 5’C*T*GGAAGGACTTCATGCCGTG*C*3’)
were designed and synthesized by Sangon Biotech Co.,
Ltd., Shanghai, China, where *represented phosphor-
othioate linkages. Oligonucleotides at dose of 60 μg/kg
were dissolved in 0.9% normal saline to a total volume
of 20 μl, and were intrathecally injected into CCI or
sham-operated rats twice a day at 8: 00AM and 6:00PM
for 5 consecutive days from the 9th to 13th day after
CCI or sham operation.
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Behavioral testing
Cold sensitivity
The cold plate test was used to determine cold sensitiv-
ity in all experiments [27]. Each rat was placed on a
copper plate cooled with ice (4 ± 2°C) under a transpar-
ent plastic cover and was allowed to acclimate for 5
min. The total number of right hind paw withdrawals
from the cold surface not related to general movement
was quantified over the subsequent 20 min period.
Mechanical sensitivity
Mechanical allodynia was assessed according to the
method of Chaplan et al [28]. Paw withdrawal threshold
(PWT, g) in response to graded mechanical stimulation
was measured using up-down method [29] with von
Frey filaments (Stoelting, NorthCoast, USA), which pro-
vide a calibrated pressure with incremental stiffness
against the hairless skin of the hindpaws.
Thermal sensitivity
Thermal hyperalgesia was measured using a 58°C hot
plate [30], and expressed as paw withdrawal latency
(PWL, s) of right hind paw. Three measurements of
thermal nociceptive threshold were taken for each rat,
at 4-minute intervals, and the mean of three measure-
ments was regarded as PWL. Maximum latency was
defined as 15 s, after which time the animals were
removed from the hot plate in order to prevent tissue
damage.
Behavioral testing was carried out before and after
menthol administration on the 14th day post-surgery. In
addition, for the experiment exploring the effect of
TRPM8 ASODN on CCI rats, behavioral testing was
performed on the 8th and 14th day following operation.
Immunohistochemistry
Four rats in each group were anaesthetized with 10%
chloral hydrate, and then perfused through the aorta
with 0.9% normal saline followed by fresh 4% parafor-
maldehyde in phosphate buffer solution (PBS) (pH 7.4)
for 10 min for tissue fixation. Then, lumbar DRGs (n =
4 in each group) at the level of L5 ipsilateral to nerve
injury were removed rapidly and placed in 4% parafor-
maldehyde in PBS for 24 h. L5 DRGs were embedded
with paraffin and prepared into slices of 4 μm. Paraffin
sections were dewaxed and antigen retrieved for 5 min
by microwave heating in citrate buffer, and then cooled
to room temperature. Sections were incubated in endo-
genous peroxidase blocker for 10 min and blocked with
normal goat serum for 20 min at room temperature.
After that, sections were incubated with TRPM8 pri-
mary antibody (1:500, Abcam, UK) overnight at 4°C.
Proper antibody diluent (Sigma, USA) was substituted
as the primary antibody for the negative controls. Then
the sections were incubated with horseradish peroxidase
(HRP)-conjugate goat anti-rabbit IgG secondary
antibody (1:500, Upstate, USA) for 45 min at 37°C. Fol-
lowed by DAB coloration, hematoxylin counterstain,
gradient dehydration, transparent and cover-slipped, sec-
tions were observed using microscope (NIKON
ECLIPSE-80i, Nikon, Japan) at 400 ×. For each L5 DRG,
three sections were selected for quantification of
TRPM8 protein level, which was expressed as the per-
centage of TRPM8 positive neurons relative to total
number of neurons, and two optical fields in each sec-
tion were randomly captured. Only neurons with clearly
visible nuclei for which optical density of TRPM8
immunoreactivity surpassed 2.5 times of the mean cyto-
plasmic density were counted as positive. The measure-
ment of TRPM8 optical density and data analysis was
performed using Image-Pro Plus 6.0 software.
In the experiment exploring the alteration of TRPM8
protein expression following CCI, four rats of each
group at each time point (before operation and on the
1st, 4th, 7th, 10th and 14th day after operation) were
killed after behavioral testing, and L5 DRGs were
removed.
In the experiments exploring the effects of menthol
and ASODN on CCI rats, the isolation of DRG was per-
formed after behavioral testing on the 14th day follow-
ing operation.
Western blotting
Another four rats in each group were anaesthetized with
10% chloral hydrate, and then only perfused with 0.9%
normal saline. Iipsilateral L5 DRGs (n = 4 in each
group) were dissected out immediately and cryopre-
served in liquid nitrogen. L5 DRGs were minced into
fragments and homogenized in lysis buffer (50 mmol/L
Tris-HCL pH 6.8, 150 mmol/L NaCl, 5 mmol/L EDTA,
0.5% sodium deoxycholate, 0.5% NP-40 and protease
inhibitor cocktail) and centrifuged (2000 g, 5 min, 4°C).
The protein concentrations were determined using a
BCA Protein Assay reagent kit (Pierce, Rockford, IL).
Protein (20 μg) was separated by SDS/PAGE, transferred
to PVDF membranes and probed with b-actin primary
antibody (1:5000, Abcam, UK) at 4°C overnight. Blots
were washed and then incubated with goat anti-mouse
IgG secondary antibody conjugated to HRP (1:5000,
Abcam, UK) for 1 h at room temperature and signals
were visualized by ECL (Amersham, Buckinghamshire,
UK). Then the membrane was stripped with restore
stripping buffer (Pierce) in order to determine TRPM8.
The procedure for determination of TRPM8 was identi-
cal to that of b-actin except that primary and secondary
antibodies were replaced by polyclonal rabbit anti-rat
antibody for TRPM8 (1:500, Abcam, UK) and HRP-con-
jugate goat anti-rabbit IgG secondary antibody (1:500,
Upstate, USA), respectively. As to the determination of
TRPV1, its procedure was identical to that of TRPM8
Su et al. BMC Neuroscience 2011, 12:120
http://www.biomedcentral.com/1471-2202/12/120
Page 13 of 15
except that the primary antibody was replaced by poly-
clonal rabbit anti-rat antibody for TRPV1 (1:500,
Abcam, UK). TRPM8 or TRPV1 densities were normal-
ized against the concentrations of b-actin, and these
ratios were used to analyze the density of bands. Quan-
titative analysis of the band densities was performed
using Quantity One Analyzer 4.5 (Bio- Rad Laboratories,
CA) in blinded fashion.
Time points for L5 DRGs dissection in western blotting
is exactly the same as that in immunohistochemistry.
Statistical analysis
The statistical program SPSS 17.0 was used. All data
were expressed as mean ± S.E.M.. Differences in beha-
vioral sensitivity as well as TRPM8 expression between
CCI rats and sham-operated rats were assessed with two
independent sample t-test. Menthol-induced behavioral
changes were determined by paired t-test. Any other
effects of the drugs were analyzed using one way-
analysis of variance (ANOVA) followed by Students-
Newman-Keuls (SNK) test for multiple comparisons.
A P value < 0.05 was considered statistically significant.
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